Serious Adverse Events In Canadian Children Receiving Palivizumab for the Prevention of Respiratory Syncytial Virus Infection
May 1, 2015, 00:00 AM
10.1016/j.jval.2015.03.1329
https://www.valueinhealthjournal.com/article/S1098-3015(15)01386-8/fulltext
Section Title :
Infection
Section Order :
789
First Page :
A228
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01386-8&doi=10.1016/j.jval.2015.03.1329